Source: People's Daily News
People's Daily Beijing, March 8 (Yang Xi) Recently, under the guidance of the Office of the Healthy China Action Promotion Committee and sponsored by the People's Daily and People's Health, the 2021 National Two Sessions "Healthy Chinese" series of roundtable forums was held in Beijing. On the afternoon of March 5, at the special forum with the theme of "Caring for the Health of Employees and Paying Attention to Early Screening of Tumors", Lei Li, co-founder of Panshengzi Health, said that the health problems of employees involve a very large population, and the early screening of cancer needs urgent attention.
Lei Li, co-founder of Panshengzi Health (Chen Chen photo)
"Liver cancer is not equal to terminal illness, and the five-year survival rate of early liver cancer can even be as high as 90%." Lei Li pointed out that it has to be admitted that liver cancer prevention and treatment in China still has a long way to go. China's 70 million hepatitis B virus carriers, 7 million cirrhosis patients, they are high-risk groups of liver cancer.
"What Panshengzi is doing is to help these high-risk groups find liver cancer at an early stage through the latest liver cancer early screening technology, which can not only improve the five-year survival rate of liver cancer, reduce the difficulty of liver cancer treatment, but also greatly reduce the cost of patient treatment, and effectively improve the quality of life of Chinese people." Lei Li introduced that according to international standards, liver cancer in the early stage refers to liver cancer that has not been metastasized far under 3cm, and the tumor is only the size of a cherry or even a blueberry, which is ablated by microwaves, and the five-year survival rate of surgery can be as high as 80%-90%. A recent early detection case was screened out by the "Liver Cancer Early Screening Comprehensive Prevention and Control Project" cooperated by Panshengzi and the National Cancer Center, who issued a positive report on December 23 last year, and the patient went to the hospital for examination on the 25th, underwent surgery on the 28th, and was discharged on December 30. Spend New Year's Day with your family. The patient is only 47 years old and he will be with his family for a long, long time. For him personally, his family, his business, his community, and his country, this is the greatest meaning of early screening.
Lei Li introduced that based on the international leading liquid biopsy detection method, HCCscreenTM, a liver cancer early screening detection technology independently developed by the National Cancer Center, obtained the US FDA breakthrough medical device certification in September last year, and is also the only domestic in vitro diagnostic company to obtain this certification; the research results of liquid biopsy liver cancer early screening have also been included in the "Guidelines for Primary Liver Cancer Patients of the Chinese Anti-Cancer Association". It is clearly proposed that the sensitivity and specificity of this technology for early screening of liver cancer are better than the traditional alpha-fetoprotein detection.
"Because we use blood samples, whether it is technology accumulation or application promotion, it is very conducive to the early screening of other cancer species, so in addition to liver cancer, we also continue to develop lung cancer and digestive tract tumors, and Panshengzi has become the only company to participate in the national early screening research and development project of liver cancer, lung cancer and digestive tract, and it is also one of the few early screening companies that actively carry out forward-looking real-world research."
Lei Li said that under the continuous guidance of the national early diagnosis and early treatment policy, with the improvement of national health awareness, we also see a broad application scenario of liquid biopsy. Panshengzi's liver cancer early screening products have been actively promoted and used in government comprehensive prevention and control projects, hospital markets, and leading domestic physical examination institutions such as iKang. In the future, as everyone understands the significance and convenience of early cancer screening, the market penetration rate of early screening will gradually increase, helping more Chinese people.
At the same time, Lei Li also stressed that doing a good job in cancer science is also a very important task. "Fanshengzi, together with our important partner iKang Group, actively promotes the importance of physical examination, before the body lights up red, to help everyone find these hidden, asymptomatic diseases, only in the golden age of curable timely treatment, the survival rate and quality of life of patients can be guaranteed."
"In the future, around the early screening of liver cancer, we will further work with iKang to provide high-value scientific cancer prevention knowledge and high-quality cancer screening services for our workplace population." Lei li said.